Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria

Inclusion Criteria: * Serum Uric Acid ≥6.0 mg/dL * eGFR ≥30 mL/min/1.73 m2 * UACR between 30 mg/g and 3500 mg/g inclusive * Diagnosed with T2DM Exclusion Criteria: * Treated with any drug for hyperuricemia in the 6 months preceding randomization.Drugs for hyperuricemia include all XO inhibitors (allopurinol, febuxostat and topiroxostat) and URAT1 inhibitors (lesinurad, verinurad, probenecid, and benzbromarone) * Prior history of gout, unless prophylaxis therapy isn't required * Patients who are pregnant, lactating, or planning to become pregnant * Patients unsuitable or unable to undergo MRI assessment